SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
Recent Articles
- Why Salesforce Stock (CRM) is an Undervalued Opportunity Today
- Mastering Market Trends: The Essential Moving Averages
- Understanding Workday's Stock Decline Amidst Strong Performance
- Exploring the Growth and Innovations in the Brachytherapy Market
- Liquid Biopsy Market Growth: A Look Towards 2030
- Global AI Inc. Welcomes Scott Clark to Revenue Leadership Role
- EnWave Corporation Shows Growth with Third Quarter Financials
- Jyong Biotech Showcases Breakthrough Research at Urological Congress
- Northrim BanCorp, Inc. Announces New Dividend for Investors
- Icelandic Hotels Sees Mixed Performance in Mid-2025 Financials
- CleanCore Solutions Achieves Record Revenue with Growth Insights
- A Closer Look at Hims & Hers Health, Inc. Class Action Alert
- Citius Oncology Enhances Commercial Strategies with AI Ahead of LYMPHIR Launch
- AprilAire Launches Game-Changing Humidifier with HydroCore Technology
- Delicious Beef Recipes for a Stress-Free School Year
- Exploring the Rapid Growth of 4D Imaging Radar Technology
- Insights from Pixalate’s MFA Benchmarks Reports for Boosting Ads
- The Future of Recycled Plastics in Sustainable Building Materials
- Liberty Defense Partners with Gold Standard Media for Expansion
- Inspira Secures U.S. Patent for ART500, Aiming for Market Growth
- CleanCore Solutions, Inc. Achieves Milestones and Record Revenue
- QCR Holdings, Inc. Declares New Cash Dividend of $0.06
- Mercurity Fintech Welcomes New Institutional Partnerships
- Merger Between Hudson Global and Star Equity Transforms Market
- Badger Infrastructure Solutions Plans to Renew Share Buyback Program
- Hudson Global and Star Equity: Strategic Merger Now Complete
- Hudson Global Announces Cash Dividend for Preferred Stockholders
- QCR Holdings, Inc. Declares Generous Cash Dividend for Stakeholders
- Hudson Global Merges with Star Equity, Expanding Opportunities
- Terra Balcanica Resources Corp. Showcases Innovations at Conference
- Hudson Global: Strategic Dividend Announcement Highlights Growth
- Investors Should Monitor These Tech Stocks Amid Market Swings
- Edgen Enhances Investor Intelligence with AI-Driven Insights
- Palo Alto Networks to Showcase Innovations at Capital Event
- Honeywell Strengthens Leadership with Peter Lau's Appointment
- OCM Solution Emerges as Leading Change Management Tool
- Empowering Innovation: O'Shaughnessy Ventures Announces Grants
- LendingTree Secures $475 Million Credit Facility for Growth
- Blockchain Founders Fund Celebrated as Singapore's VC Leader
- Transforming Finance: The Future of Open Banking Solutions
- Cenovus Energy's $7.9 Billion Acquisition: A Game Changer
- Google Launches Affordable AI Suite for Federal Use
- Nvidia Faces Revenue Risks Amid China's AI Market Changes
- Gentex Corporation Declares Quarterly Dividend Amid Growth
- Century Therapeutics Announces Presentation at Global Investment Event
- Gustavo Usero Lands COO Role at Nuvini Group to Drive Growth
- Winvest Group and BioCalth Forge Alliance for Growth in DTC Market
- Ninepoint Expands ETF Offerings with New Canadian Stocks
- VanEck's Transition to ETF: Enhancing Investor Accessibility
- El Salvador's Innovative Bitcoin Education Program Hits Milestone